HUP0101809A2 - 5-és 3-as típusú 17béta-hidroxi-szteroid dehidrogenáz inhibitorok és ezeket tartalmazó gyógyászati készítmények - Google Patents
5-és 3-as típusú 17béta-hidroxi-szteroid dehidrogenáz inhibitorok és ezeket tartalmazó gyógyászati készítményekInfo
- Publication number
- HUP0101809A2 HUP0101809A2 HU0101809A HUP0101809A HUP0101809A2 HU P0101809 A2 HUP0101809 A2 HU P0101809A2 HU 0101809 A HU0101809 A HU 0101809A HU P0101809 A HUP0101809 A HU P0101809A HU P0101809 A2 HUP0101809 A2 HU P0101809A2
- Authority
- HU
- Hungary
- Prior art keywords
- type
- 17betha
- inhibitors
- methods
- hydroxysteroid dehydrogenase
- Prior art date
Links
- 101710088194 Dehydrogenase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7751098P | 1998-03-11 | 1998-03-11 | |
US9562398P | 1998-08-07 | 1998-08-07 | |
PCT/CA1999/000205 WO1999046279A2 (en) | 1998-03-11 | 1999-03-10 | INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0101809A2 true HUP0101809A2 (hu) | 2001-12-28 |
HUP0101809A3 HUP0101809A3 (en) | 2002-07-29 |
Family
ID=26759352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0101809A HUP0101809A3 (en) | 1998-03-11 | 1999-03-10 | Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use |
Country Status (15)
Country | Link |
---|---|
US (2) | US6541463B1 (hu) |
EP (1) | EP1094798A2 (hu) |
JP (1) | JP2002506077A (hu) |
CN (1) | CN1429104A (hu) |
AU (1) | AU2707999A (hu) |
BR (1) | BR9908592A (hu) |
CA (1) | CA2323089A1 (hu) |
HK (1) | HK1053054A1 (hu) |
HU (1) | HUP0101809A3 (hu) |
IL (1) | IL128942A (hu) |
MX (1) | MXPA00008868A (hu) |
PL (1) | PL343862A1 (hu) |
RU (1) | RU2000125533A (hu) |
TR (1) | TR200002784T2 (hu) |
WO (1) | WO1999046279A2 (hu) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19825591A1 (de) * | 1998-06-09 | 1999-12-23 | Jenapharm Gmbh | Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata |
CA2339368A1 (en) * | 1998-08-07 | 2000-02-17 | Endorecherche, Inc. | Inhibitors of type 3 3.alpha.-hydroxysteroid dehydrogenase |
US20050223587A1 (en) * | 2002-01-22 | 2005-10-13 | Biomatera Inc. | Method of drying biodegradable polymers |
ES2345146T3 (es) | 2002-11-18 | 2010-09-16 | Schering Corporation | Inhibidores de 17beta-hidroxiesteroides deshidrogenasa de tipo 3 para el tratamiento de enfermedades dependientes de androgenos. |
WO2004060488A1 (en) * | 2002-12-17 | 2004-07-22 | Schering Corporation | 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
US20040224935A1 (en) * | 2003-04-07 | 2004-11-11 | Endorecherche, Inc. | Topical antiandrogenic steroids |
US7465739B2 (en) * | 2003-06-10 | 2008-12-16 | Solvay Pharmaceuticals B.V. | Compounds and their use in therapy |
US7754709B2 (en) * | 2003-06-10 | 2010-07-13 | Solvay Pharmaceuticals Bv | Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds |
JP4866740B2 (ja) | 2004-01-07 | 2012-02-01 | アンドルシェルシュ・インコーポレイテッド | へリックス12指向ステロイド系医薬品 |
US7417040B2 (en) | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7138246B2 (en) | 2004-03-01 | 2006-11-21 | Bristol-Myers Squibb Company | Methods for identifying or screening for agents that modulate 17β-HSD3 |
DE102004032674A1 (de) * | 2004-07-02 | 2006-01-26 | Schering Ag | Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1 |
US7419972B2 (en) | 2004-07-02 | 2008-09-02 | Schering Ag | 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
DE102004032673A1 (de) * | 2004-07-02 | 2006-01-26 | Schering Ag | Neue 2-substituierte D-Homo-estra-1,3,5(10)-triene als Inhibitoren der 17ß-Hydroxysteroiddehydrogenase Typ 1 |
US7435757B2 (en) * | 2004-07-02 | 2008-10-14 | Schering Ag | 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
US20060073099A1 (en) * | 2004-10-01 | 2006-04-06 | Frincke James M | Treatment screening methods |
US7569725B2 (en) | 2004-10-21 | 2009-08-04 | Britsol-Myers Squibb Company | Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7709516B2 (en) | 2005-06-17 | 2010-05-04 | Endorecherche, Inc. | Helix 12 directed non-steroidal antiandrogens |
GB0513702D0 (en) | 2005-07-04 | 2005-08-10 | Sterix Ltd | Compound |
MX2008011127A (es) * | 2006-03-02 | 2008-10-31 | Astellas Pharma Inc | INHIBIDOR DE 17ß HSD TIPO 5. |
US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
US8288367B2 (en) * | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
CA2671075A1 (en) * | 2006-11-30 | 2008-06-05 | Solvay Pharmaceuticals Gmbh | Substituted estratrien derivatives as 17beta hsd inhibitors |
US9284345B2 (en) | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
EP2172454A4 (en) | 2007-07-24 | 2010-12-08 | Astellas Pharma Inc | benzimidazole derivative |
AU2008292420A1 (en) * | 2007-08-31 | 2009-03-05 | Astellas Pharma Inc. | Piperidine derivative |
GB0722779D0 (en) | 2007-11-20 | 2008-01-02 | Sterix Ltd | Compound |
WO2010087319A1 (ja) | 2009-01-27 | 2010-08-05 | アステラス製薬株式会社 | 前立腺癌治療剤として有効な物質のスクリーニング方法 |
JP5609150B2 (ja) * | 2009-02-27 | 2014-10-22 | アステラス製薬株式会社 | ピペリジン誘導体 |
JP2011057643A (ja) * | 2009-09-14 | 2011-03-24 | Sumitomo Chemical Co Ltd | 3型17β−ヒドロキシステロイドデヒドロゲナーゼを阻害するための化合物の使用およびそのための医薬組成物 |
JP2011057644A (ja) * | 2009-09-14 | 2011-03-24 | Sumitomo Chemical Co Ltd | 3型17β−ヒドロキシステロイドデヒドロゲナーゼを阻害するための化合物の使用およびそのための医薬組成物 |
CN102134265B (zh) * | 2009-12-29 | 2013-04-03 | 黄云生 | 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法 |
CN102952169B (zh) * | 2011-08-16 | 2015-11-11 | 黄云生 | 6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮合成方法 |
DE102011083725A1 (de) * | 2011-09-29 | 2013-04-04 | Bayer Pharma AG | Estra-1,3,5(10),16-tetraen-3-carboxamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
EA201500112A1 (ru) | 2012-07-10 | 2015-07-30 | Байер Фарма Акциенгезельшафт | 3-замещенные производные эстра-1,3,5(10),16-тетраена, способы их получения, фармацевтические средства, которые их содержат, и их использование для получения лекарственных средств |
US9714266B2 (en) * | 2013-02-21 | 2017-07-25 | Bayer Pharma Aktiengesellschaft | Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3) |
US10377791B2 (en) | 2013-06-25 | 2019-08-13 | Forendo Pharma Ltd. | Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 |
WO2014207311A1 (en) | 2013-06-25 | 2014-12-31 | Forendo Pharma Ltd | Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxy-steroid dehydrogenase, type 1 |
US9663549B2 (en) | 2013-06-25 | 2017-05-30 | Forendo Pharma Ltd. | Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase |
US9682960B2 (en) | 2013-12-19 | 2017-06-20 | Endorecherche, Inc. | Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety |
WO2016102775A1 (en) | 2014-12-23 | 2016-06-30 | Forendo Pharma Ltd | PRODRUGS OF 17β-HSD1 -INHIBITORS |
JP6523461B2 (ja) | 2014-12-23 | 2019-06-05 | フォレンド ファーマ リミテッド | 17β−HSD1−阻害剤のプロドラッグ |
US10167293B2 (en) | 2016-05-26 | 2019-01-01 | Bayer Pharma Aktiengesellschaft | [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones |
CZ307437B6 (cs) | 2016-06-07 | 2018-08-22 | Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. | 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz |
TW201825478A (zh) | 2016-12-19 | 2018-07-16 | 德商拜耳製藥公司 | [4-(苯基磺醯基)哌嗪-1--基](1h-1,2,3-三唑-4-基)甲酮 |
CA3047196A1 (en) | 2016-12-19 | 2018-06-28 | Bayer Pharma Aktiengesellschaft | [(phenylsulfonyl)octahydro-epiminoisoindol-yl](1h-1,2,3-triazol-5-yl)methanones |
WO2018114672A1 (en) | 2016-12-19 | 2018-06-28 | Bayer Pharma Aktiengesellschaft | [4-(phenylsulfonyl)piperazin-1-yl](1h-1,2,3-triazol-4-yl)methanones |
RU2021133626A (ru) | 2017-01-23 | 2022-01-31 | Регенерон Фармасьютикалз, Инк. | Варианты hsd17b13 и их применения |
CN110325649A (zh) | 2017-04-11 | 2019-10-11 | 雷杰纳荣制药公司 | 用于筛选羟基类固醇(17-β)脱氢酶(HSD17B)家族成员的调节剂的活性的测定法 |
WO2018224736A2 (en) | 2017-06-08 | 2018-12-13 | Forendo Pharma Ltd | Therapeutically active steroidal derivatives |
EP3421483A1 (en) | 2017-06-29 | 2019-01-02 | Bayer Pharma Aktiengesellschaft | Novel steroidal 17-beta heteroaryl compounds as inhibitors of akr1c3 |
EP4234719A3 (en) | 2017-10-11 | 2023-10-18 | Regeneron Pharmaceuticals, Inc. | Inhibition of hsd17b13 in the treatment of liver disease in patients expressing the pnpla3 i148m variation |
JP7417608B2 (ja) | 2018-12-05 | 2024-01-18 | フォレンド ファーマ リミテッド | 17-hsd1阻害剤としての16(17)位でピラゾール環と縮合しているエストラ-1,3,5(10)-トリエン化合物 |
CN114057821B (zh) * | 2021-11-30 | 2022-12-09 | 黑龙江中医药大学 | 用于围绝经期综合征的醋酸甲羟孕酮的制备方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2875199A (en) * | 1958-04-22 | 1959-02-24 | Searle & Co | Lactones of 17-carboxyalkylated estra-1, 3, 5(10)-triene-3, 17-diols and 3-ethers |
GB870286A (en) | 1958-11-04 | 1961-06-14 | British Drug Houses Ltd | Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds |
FR1405214A (fr) | 1962-06-21 | 1965-07-09 | Rhone Poulenc Sa | Nouveaux stéroïdes de la série du prégnane et leur procédé de préparation |
US3917657A (en) | 1970-03-04 | 1975-11-04 | Philips Corp | 16-Methylene-17-acyloxy-9{62 ,10-{60 -pregna-4,6-dinene-3,20 diones and methods of producing same |
DE2059338C3 (de) | 1970-11-27 | 1980-01-24 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verwendung von Cyproteronacetat bei der Behandlung der Pubertas praecox |
DE2817157A1 (de) * | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
DE3121152A1 (de) | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie" |
ZA837859B (en) | 1982-10-21 | 1984-11-28 | Christopher Harry Mortimer | Treatment of male scalp hair loss |
JPS6028926A (ja) | 1983-07-28 | 1985-02-14 | Shiseido Co Ltd | 皮膚外用剤 |
JPS60126214A (ja) | 1983-12-14 | 1985-07-05 | Kazuoki Tsuchiya | 養毛剤 |
US4684635A (en) | 1984-05-11 | 1987-08-04 | Norman Orentreich | Compositions and methods for inhibiting the action of androgens |
AU594309B2 (en) | 1984-08-02 | 1990-03-08 | Fernand Labrie | Pharmaceutical composition for combination therapy of hormonedependent cancers |
US4659695A (en) | 1985-02-08 | 1987-04-21 | Fernand Labrie | Method of treatment of prostate cancer |
US4666885A (en) | 1985-02-08 | 1987-05-19 | Fernand Labrie | Combination therapy for treatment of female breast cancer |
WO1986001402A1 (en) | 1984-09-05 | 1986-03-13 | Schering Aktiengesellschaft | Means for handling androgenization phenomena and use of antiandrogens for the production thereof |
HU221589B (hu) * | 1989-03-10 | 2002-11-28 | Endorecherche Inc. | Emlő- és méhrák kezelésére alkalmas kombinációs gyógyszerkészítmény és eljárás előállítására |
DE69034035T2 (de) | 1989-07-07 | 2004-01-22 | Endorecherche Inc., Ste-Foy | Methode zur behandlung androgenbedingter krankheiten |
DE69034148T2 (de) | 1989-07-07 | 2005-06-30 | Endorecherche Inc., Ste-Foy | Kombinationstherapie zur Prophylaxe und/oder Behandlung von gutartiger prostatischer Hyperplasie |
US5227375A (en) | 1990-02-08 | 1993-07-13 | Endorecherche, Inc. | Aromatase inhibitors |
JP2985007B2 (ja) * | 1990-02-09 | 1999-11-29 | 武田薬品工業株式会社 | 血管新生阻害剤 |
HU222501B1 (hu) | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
US6060503A (en) | 1991-12-02 | 2000-05-09 | Endorecherche, Inc. | Benzopyran-containing compounds and method for their use |
CZ285893B6 (cs) | 1993-05-17 | 1999-11-17 | Endorecherche Inc. | Antiandrogenní sloučenina, její prekursor a farmaceutický prostředek ji obsahující |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
WO1996015794A1 (en) * | 1994-11-22 | 1996-05-30 | Balance Pharmaceuticals, Inc. | Compositions and methods for contraception and for treatment of benign gynecological disorders |
US6124115A (en) | 1995-09-22 | 2000-09-26 | Endorecherche Inc. | Production and use of isolated type 5 17β-hydroxysteroid dehydrogenase |
-
1999
- 1999-03-10 EP EP99907207A patent/EP1094798A2/en not_active Withdrawn
- 1999-03-10 WO PCT/CA1999/000205 patent/WO1999046279A2/en not_active Application Discontinuation
- 1999-03-10 CA CA002323089A patent/CA2323089A1/en not_active Abandoned
- 1999-03-10 MX MXPA00008868A patent/MXPA00008868A/es unknown
- 1999-03-10 US US09/265,807 patent/US6541463B1/en not_active Expired - Fee Related
- 1999-03-10 PL PL99343862A patent/PL343862A1/xx unknown
- 1999-03-10 JP JP2000535656A patent/JP2002506077A/ja active Pending
- 1999-03-10 TR TR2000/02784T patent/TR200002784T2/xx unknown
- 1999-03-10 BR BR9908592-5A patent/BR9908592A/pt not_active IP Right Cessation
- 1999-03-10 HU HU0101809A patent/HUP0101809A3/hu unknown
- 1999-03-10 RU RU2000125533/14A patent/RU2000125533A/ru not_active Application Discontinuation
- 1999-03-10 AU AU27079/99A patent/AU2707999A/en not_active Abandoned
- 1999-03-10 CN CN99803912A patent/CN1429104A/zh active Pending
- 1999-03-11 IL IL12894299A patent/IL128942A/en not_active IP Right Cessation
-
2001
- 2001-11-01 HK HK03105229.9A patent/HK1053054A1/zh unknown
-
2002
- 2002-11-26 US US10/305,603 patent/US20040082556A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1429104A (zh) | 2003-07-09 |
TR200002784T2 (tr) | 2000-12-21 |
MXPA00008868A (es) | 2003-04-25 |
BR9908592A (pt) | 2001-04-24 |
IL128942A (en) | 2004-07-25 |
US20040082556A1 (en) | 2004-04-29 |
PL343862A1 (en) | 2001-09-10 |
HK1053054A1 (zh) | 2003-10-10 |
HUP0101809A3 (en) | 2002-07-29 |
RU2000125533A (ru) | 2002-10-20 |
WO1999046279A3 (en) | 2001-02-22 |
JP2002506077A (ja) | 2002-02-26 |
AU2707999A (en) | 1999-09-27 |
CA2323089A1 (en) | 1999-09-16 |
EP1094798A2 (en) | 2001-05-02 |
US6541463B1 (en) | 2003-04-01 |
WO1999046279A2 (en) | 1999-09-16 |
IL128942A0 (en) | 2000-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0101809A3 (en) | Inhibitors of type 5 and type 3 17betha-hydroxysteroid dehydrogenase and methods for their use | |
HU9700602D0 (en) | New inhibitors of bone-resorption and vitronectine-receptor-antagonists | |
PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
IL128226A0 (en) | Hppd gene and inhibitors | |
PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
PL344589A1 (en) | COMPOSITION COMPRISING β-HYDROXY-β-METHYLBUTYRIC ACID AND AT LEAST ONE AMINO ACID AND METHODS OF USE | |
EP1009415A4 (en) | INHIBITORS OF $ g (b) -LACTAMASES AND THEIR USES | |
SI1475377T1 (sl) | Indolni derivati in njihova uporaba kot inhibitorji fosfodiesteraze 4 | |
EP1115389A4 (en) | ANTAGONISTS AND AGONISTS OF FRUCTOSAMINE OXIDASE | |
HU9702036D0 (en) | New heterocyclic compounds as inhibitors of leucocita-adhesion and wla-4-antagonists | |
IL152753A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
GB9422571D0 (en) | Haemorrihoidal compositions and method of use | |
IL127748A0 (en) | Electronic coupon and methods for creation and use of same | |
IL128217A0 (en) | Phosphatase inhibitors and methods of use thereof | |
ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
PL331047A1 (en) | Novel amidinic derivatives and their application as inhibitors of thrombosin | |
EP1069901A4 (en) | CALCILYTIC COMPOUNDS AND THEIR USE | |
AU3124300A (en) | Inhibitors of beta-lactamases and uses therefor | |
AU2190400A (en) | Inhibitors of beta-lactamases and uses therefor | |
ZA9711548B (en) | Ricin inhibitors and methods for use thereof | |
HK1066804A1 (en) | Derivatives of indole and their use as phosphodiesterase 4 inhibitors | |
ZA9710989B (en) | Polyprolyl inhibitors of cyclophilin | |
HK1041878A1 (zh) | 二羥吡啶化合物和其用作鉀通道開放劑的用途 | |
ZA991924B (en) | Inhibitors of type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use. | |
AU5913199A (en) | Methazolamide compositions and method of use |